Target Pullback Viewed as Buying Opportunity and 4 Stock Analyses Not to Miss

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Bristol-Myers Squibb Company (NYSE:BMY): Current price $36.90

Cowen raised their sales and earnings estimates for Bristol-Myers Squibb Company to reflect P&L leverage potential from new drugs including Eliquis. The firm noted that they did not have any estimates in their model for the failed prostate drug, Sprycel, but sees increase in new products. Shares are Outperform rated.

These stocks are hitting our Profit Targets. Click here now to discover winning stocks!

bmy

More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business